A randomized double-blind placebo-controlled study

Project: Research project

Project Details

Description

A randomized double-blind placebo-controlled study to evaluate the efficacy and safety of Cinryze?? (C1 esterase inhibitor [human]) for the treatment of acute antibody-mediated rejection in kidney transplant patients
StatusFinished
Effective start/end date6/15/156/14/20

Funding

  • SHIRE HUMAN GENETIC THERAPIES, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.